Home Newsfeeds William Blair Initiates Coverage On POINT Biopharma Global with Outperform Rating

William Blair Initiates Coverage On POINT Biopharma Global with Outperform Rating

William Blair analyst Andy Hsieh initiates coverage on POINT Biopharma Global (NASDAQ:PNT) with a Outperform rating.

byBenzinga Newsdesk

July 6, 2022

1 minute read

William Blair analyst Andy Hsieh initiates coverage on POINT Biopharma Global (NASDAQ:PNT) with a Outperform rating.

BMO Capital Maintains Outperform on Zscaler, Raises Price Target to $200

By Benzinga Newsdesk

September 9, 7:24 AM

BMO Capital analyst Keith Bachman maintains Zscaler (NASDAQ:ZS) with a Outperform and raises the price target from $172 to $200.

Dyadic International Q2 EPS $(0.12) Misses $(0.09) Estimate, Sales $628.553K Miss $1.84M Estimate; Cash Position $15.7M

By Bill Haddad

August 10, 4:01 PM

Dyadic International (NASDAQ:DYAI) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.09) by 33.33 percent. This is a 14.29 percent increase over losses of $(0.14) per share from the same period last year.

DYAI

MamaMancini’s Appoints Anthony Gruber As Finance Chief

By Shivani Kumaresan

September 12, 1:27 PM

MamaMancini’s Holdings Inc (NASDAQ:MMMB) has appointed Anthony J. Gruber as its Chief Financial Officer, effective September 19, 2022. Gruber has a strong…

MMMB